The continuous emergence of SARS-CoV-2 variants has led to a protracted global COVID-
19 pandemic with significant impacts on public health and global economy. While there are …

Since December 2019, the emergence of severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) has caused severe pneumonia, a disease named COVID-19, that became …

The wild-type SARS-CoV-2 has continuously evolved into several variants with increased
transmissibility and virulence. The Delta variant which was initially identified in India created …

The frequent occurrence of viral infections poses a serious threat to human life. Identifying
effective antiviral components is urgent. In China, pearls have been important traditional …

The novel Coronavirus disease 2019 (COVID-19) is the cause behind the current global
pandemic, capable of inducing pneumonia-like symptoms and lung failure. A key pathway …

Abstract Coronavirus disease 2019 (COVID‐19) is caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Several vaccines against SARS‐CoV‐2 …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters into the cells
through its spike proteins binding to human angiotensin-converting enzyme 2 (ACE2) …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
extensively and rapidly spread in the world, causing an outbreak of acute infectious …

The novel coronavirus (nCoV) has emerged as a severe public health threat globally in the
21st century. Several therapies were reported towards identifying ligand against …

Abstract Objective Anemoside B4 (AB4), the most abundant triterpenoidal saponin isolated
from Pulsatilla chinensis, inhibited influenza virus FM1 or Klebsiella pneumoniae-induced …